BRIEF-Apyx Medical Corp Reports Q3 2024 Results, Updates 2024 Outlook And Introduces 2025 Financial Outlook

Reuters11-08

Nov 8 (Reuters) - Apyx Medical Corp :

* APYX MEDICAL CORPORATION REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS; UPDATES FULL YEAR 2024 FINANCIAL OUTLOOK AND INTRODUCES FULL YEAR 2025 FINANCIAL OUTLOOK

* APYX MEDICAL CORP: ANNOUNCES COST SAVINGS RESTRUCTURING PROGRAM

* APYX MEDICAL CORP: NEARLY 25% REDUCTION IN U.S. WORKFORCE

* APYX MEDICAL CORP: ANNUALIZED FUTURE COST SAVINGS FROM REDUCTION IN FORCE IS ESTIMATED TO BE APPROXIMATELY $4.3 MILLION

* APYX MEDICAL CORP: RIGHT SIZED COMPANY'S BOARD OF DIRECTORS TO FIVE MEMBERS DOWN FROM EIGHT

* APYX MEDICAL CORP OUTLOOK FY TOTAL REVENUE $46.6 MILLION TO $47.6 MILLION

* APYX MEDICAL CORP OUTLOOK FY 2025 TOTAL REVENUE $47.6 MILLION TO $49.5 MILLION

Source text: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2481171358?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-08 20:25","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2481171358","market":"us","top_or_hot":-1,"title":"BRIEF-Apyx Medical Corp Reports Q3 2024 Results, Updates 2024 Outlook And Introduces 2025 Financial Outlook","media":"Reuters","content":"<html><body><p>Nov 8 (Reuters) - Apyx Medical Corp   :</p><p>   * APYX MEDICAL CORPORATION REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS; UPDATES FULL YEAR 2024 FINANCIAL OUTLOOK AND INTRODUCES FULL YEAR 2025 FINANCIAL OUTLOOK</p><p>   * APYX MEDICAL CORP: ANNOUNCES COST SAVINGS RESTRUCTURING PROGRAM</p><p>   * APYX MEDICAL CORP: NEARLY 25% REDUCTION IN U.S. WORKFORCE</p><p>   * APYX MEDICAL CORP: ANNUALIZED <a href=\"https://laohu8.com/S/FUTR.UK\">FUTURE</a> COST SAVINGS FROM REDUCTION IN FORCE IS ESTIMATED TO BE APPROXIMATELY $4.3 MILLION</p><p>   * APYX MEDICAL CORP: RIGHT SIZED COMPANY'S BOARD OF DIRECTORS TO FIVE MEMBERS DOWN FROM EIGHT</p><p>   * APYX MEDICAL CORP OUTLOOK FY TOTAL REVENUE $46.6 MILLION TO $47.6 MILLION</p><p>   * APYX MEDICAL CORP OUTLOOK FY 2025 TOTAL REVENUE $47.6 MILLION TO $49.5 MILLION</p><p>Source text:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Apyx Medical Corp Reports Q3 2024 Results, Updates 2024 Outlook And Introduces 2025 Financial Outlook</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Apyx Medical Corp Reports Q3 2024 Results, Updates 2024 Outlook And Introduces 2025 Financial Outlook\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-08 20:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Nov 8 (Reuters) - Apyx Medical Corp   :   * APYX MEDICAL CORPORATION REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS; UPDATES FULL YEAR 2024 FINANCIAL OUTLOOK AND INTRODUCES FULL YEAR 2025 FINANCIAL ...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"APYX","symbol_name":"Apyx Medical Inc","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2481171358","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2481171358","pubTimestamp":1731068743,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Nov 8  - Apyx Medical Corp   :   * APYX MEDICAL CORPORATION REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS; UPDATES FULL YEAR 2024 FINANCIAL OUTLOOK AND INTRODUCES FULL YEAR 2025 FINANCIAL OUTLOOK   * APYX MEDICAL CORP: ANNOUNCES COST SAVINGS RESTRUCTURING PROGRAM   * APYX MEDICAL CORP: NEARLY 25% REDUCTION IN U.S. WORKFORCE   * APYX MEDICAL CORP: ANNUALIZED FUTURE COST SAVINGS FROM REDUCTION IN FORCE IS ESTIMATED TO BE APPROXIMATELY $4.3 MILLION   * APYX MEDICAL CORP: RIGHT SIZED COMPANY'S BOARD OF DIRECTORS TO FIVE MEMBERS DOWN FROM EIGHT   * APYX MEDICAL CORP OUTLOOK FY TOTAL REVENUE $46.6 MILLION TO $47.6 MILLION   * APYX MEDICAL CORP OUTLOOK FY 2025 TOTAL REVENUE $47.6 MILLION TO $49.5 MILLIONSource text:    Further company coverage:    ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"APYX":"Apyx Medical Inc","BK4082":"医疗保健设备"},"translate_title":"简介-Apyx Medical Corp报告2024年第三季度业绩、更新2024年展望并介绍2025年财务展望","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"APYX":0.9},"content_text":"Nov 8 (Reuters) - Apyx Medical Corp   :   * APYX MEDICAL CORPORATION REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS; UPDATES FULL YEAR 2024 FINANCIAL OUTLOOK AND INTRODUCES FULL YEAR 2025 FINANCIAL OUTLOOK   * APYX MEDICAL CORP: ANNOUNCES COST SAVINGS RESTRUCTURING PROGRAM   * APYX MEDICAL CORP: NEARLY 25% REDUCTION IN U.S. WORKFORCE   * APYX MEDICAL CORP: ANNUALIZED FUTURE COST SAVINGS FROM REDUCTION IN FORCE IS ESTIMATED TO BE APPROXIMATELY $4.3 MILLION   * APYX MEDICAL CORP: RIGHT SIZED COMPANY'S BOARD OF DIRECTORS TO FIVE MEMBERS DOWN FROM EIGHT   * APYX MEDICAL CORP OUTLOOK FY TOTAL REVENUE $46.6 MILLION TO $47.6 MILLION   * APYX MEDICAL CORP OUTLOOK FY 2025 TOTAL REVENUE $47.6 MILLION TO $49.5 MILLIONSource text:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2481171358"}